Πλοήγηση ανά Συγγραφέα "Moutsopoulos, H. M."
-
Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations
Mavragani, C. P.; Danielides, S.; Zintzaras, E.; Vlachoyiannopoulos, P. G.; Moutsopoulos, H. M. (2009)Autoimmune thyroid disease has been associated with several systemic autoimmune disorders. However, limited data are available regarding the prevalence and clinical associations of thyroid autoimmunity in antiphospholipid ... -
Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study
Giannouli, S.; Voulgarelis, M.; Zintzaras, E.; Tzioufas, A. G.; Moutsopoulos, H. M. (2004)Objective. To determine the clinical aspects and evolution of autoimmune inflammatory manifestations (AIMs) in patients with myelodysplastic syndrome (MDS) and ascertain the prognostic implications of these manifestations ... -
Autoimmune phenomena in myelodysplastic syndromes: A four year prospective study
Giannouli, S.; Voulgarelis, M.; Zintzaras, E.; Tzioufas, A. G.; Moutsopoulos, H. M. (2004) -
Cyclophosphamide therapy for renal involvement in SLE: When to discontinue in responders? When to consider it has failed?
Vlachoyiannopoulos, P. G.; Samarkos, M.; Fotia, M.; Zintzaras, E.; Boletis, J.; Moutsopoulos, H. M. (2005) -
HLA DR-DQ haplotypes and genotypes in patients with systemic lupus erythematosus with co-existing Sjogren's syndrome, systemic lupus erythematosus without Sjogren's syndrome and primary Sjogren's syndrome: clinical and laboratory associations
Georgopoulou, C.; Zintzaras, E.; Papadimitropouls, M.; Spyropoulou, M.; Stavropoulou, A.; Moutsopoulos, H. M.; Manoussakis, M. N. (2005) -
Immunogenetic associations in patients with primary Sjogren's syndrome (pSS), SLE with co-existing Sjogren's syndrome (SLE-SS) and SLE without Sjogren's syndrome (SLE-noSS)
Georgopoulou, C.; Zintzaras, E.; Papadimitropoulos, M.; Spyropoulou, M.; Stavropoulou, A.; Skopouli, F. N.; Moutsopoulos, H. M.; Manoussakis, M. N. (2004) -
Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjogren's syndrome
Fragoulis, G. E.; Vakrakou, A. G.; Papadopoulou, A.; Germenis, A.; Kanavakis, E.; Moutsopoulos, H. M.; Manoussakis, M. N. (2015)Aberrant removal of necrotic debris is considered a feature with inflammatory consequences in SLE. Herein, primary Sjogren's syndrome (SS) patients were investigated for the first time for the capacity of their sera to ... -
Impaired elastic properties of ascending aorta in patients with giant cell arteritis
Margos, P. N.; Moyssakis, I. E.; Tzioufas, A. G.; Zintzaras, E.; Moutsopoulos, H. M. (2005)Objective: To investigate the elastic properties of the ascending aorta in untreated patients with giant cell arteritis compared with age and sex matched normal controls. Methods: Distensibility of the ascending aorta and ... -
Impaired elastic properties of ascending aorta in patients with giant cell arteritis
Margos, P. N.; Moyssakis, I. E.; Tzioufas, A. G.; Zintzaras, E.; Moutsopoulos, H. M. (2004) -
Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma
Danielides, S.; Mavragani, C. P.; Katsakoulas, I.; Zintzaras, E.; Drosos, A. A.; Vlachoyiannopoulos, P. G.; Moutsopoulos, H. M. (2011)Objectives: Thyroid dysfunction in the setting of systemic sclerosis (SSc) has been described previously. We aimed to determine the prevalence of anti-thyroid antibodies (ATA) in a large SSc cohort and to ascertain whether ... -
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Dosage Regimens
Zintzaras, E.; Dahabreh, I. J.; Giannouli, S.; Voulgarelis, M.; Moutsopoulos, H. M. (2008)Background: Because of its long-term effectiveness in clinical practice, methotrexate (MTX) is currently the preferred disease-modifying antirheumatic drug (DMARD) for patients with active rheumatoid arthritis (RA). However, ... -
Infliximab therapy for patients with active and refractory spondyloarthropathies at the dose of 3 mg/kg: A 20-month open treatment
Cherouvim, E. P.; Zintzaras, E.; Boki, K. A.; Moutsopoulos, H. M.; Manoussakis, M. N. (2004)Background: Infliximab at the dose of 5 mg/kg per infusion has been shown effective for the treatment of active spondyloarthropathies. It is not clear if the 5 mg/kg is required in most patients. Objective: To evaluate the ... -
JAK2 V617F-POSITIVE CHRONIC EOSINOPHILIC LEUKEMIA: CLINICAL, LABORATORY AND MOLECULAR DEFINITION OF A DISTINCT DISEASE SUBTYPE
Zoi, K.; Dahabreh, I. J.; Zoi, C.; Helbig, G.; Krzemien, S.; Gota, V.; Speletas, M.; Giannouli, S.; Palliou, A.; Stefanoudaki, K.; Harhalakis, N.; Vassilopoulos, G.; Kotsopoulou, M.; Tsirigotis, P.; Moutsopoulos, H. M.; Loukopoulos, D.; Voulgarelis, M. (2009) -
Morbidity, Mortality, and Organ Damage in Patients with Antiphospholipid Syndrome
Grika, E. P.; Ziakas, P. D.; Zintzaras, E.; Moutsopoulos, H. M.; Vlachoyiannopoulos, P. G. (2012)Objective. To describe morbidity, organ damage, mortality, and cause of death in patients with antiphospholipid syndrome (APS). Methods. Descriptive analysis of 135 patients. Patients were clustered according to initial ... -
Predicting the Outcome of Sjogren's Syndrome-Associated non-Hodgkin's Lymphoma Patients
Papageorgiou, A.; Ziogas, D. C.; Mavragani, C. P.; Zintzaras, E.; Tzioufas, A. G.; Moutsopoulos, H. M.; Voulgarelis, M. (2015) -
Psychiatric symptoms associated with scleroderma
Angelopoulos, N. V.; Drosos, A. A.; Moutsopoulos, H. M. (2001)Background: The prevalence of psychiatric symptoms and hostility factors in patients with scleroderma, although a matter of clinical interest, it is rather poorly studied. Methods: Thirty female patients with scleroderma ... -
Psychopathological and personality features in primary Sjogren's syndrome-associations with autoantibodies to neuropeptides
Karaiskos, D.; Mavragani, C. P.; Sinno, M. H.; Dechelotte, P.; Zintzaras, E.; Skopouli, F. N.; Fetissov, S. O.; Moutsopoulos, H. M. (2010)Methods. Personality and psychopathological variables were determined in 103 pSS patients and 110 healthy controls (HCs). AutoAbs against hypothalamic and pituitary neuropeptides were measured by ELISA in 25 pSS patients ... -
Quantitation of anti-Ro52 autoantibodies identifies distinct clinical subgroups among patients with primary sjogren's syndrome (pSS)
Tsonis, I. A.; Routsias, J. G.; Stea, E. A.; Zintzaras, E.; Avrameas, S.; Moutsopoulos, H. M.; Tzioufas, A. G. (2006) -
The risk of lymphoma development in autoimmune diseases: A meta-analysis
Zintzaras, E.; Voulgarelis, M.; Moutsopoulos, H. M. (2005)Background: The risk of development of non-Hodgkin lymphoma (NHL) in autoimmune patients has been investigated in several cohort studies. These studies revealed inconclusive results. To shed some light on this controversy, ... -
Sjogren's syndrome associated with systemic lupus erythematosus - Clinical and laboratory profiles and comparison with primary Sjogren's syndrome
Manoussakis, M. N.; Georgopoulou, C.; Zintzaras, E.; Spyropoulou, M.; Stavropoulou, A.; Skopouli, F. N.; Moutsopoulos, H. M. (2004)Objective. To address the clinical, serologic, pathologic, and immunogenetic features of sicca syndrome that occurs in systemic lupus erythematosus (SLE), as well as its similarities to, and differences from, sicca syndrome ...